The effects of hesperidin on stricture formation in corrosive esophageal burns: an experimental study

Meryem Anayurt1, Ayşe Karaman1, Özlem Balcı2

  • 1Department of Pediatric Surgery, University of Health Sciences Turkey, Dr Sami Ulus Maternity and Children's Health and Diseases Training and Research Hospital, Beştepeler Mah, Alparslan Türkeş Cad. No: 27, 06560, Beştepe/Ankara, Turkey.

Insights

Hesperidin effectively reduced esophageal stricture formation and histopathological damage in a rat model of corrosive esophageal burns. This bioflavonoid also positively impacted nutrition, offering a promising therapeutic strategy for such injuries.

Area of Science:

  • Gastroenterology
  • Pharmacology
  • Toxicology

Background:

  • Accidental ingestion of corrosive substances causes esophageal strictures in children, posing a significant health concern.
  • Bioflavonoids like Hesperidin show potential in managing inflammatory processes.

Purpose of the Study:

  • To investigate the efficacy of Hesperidin in preventing esophageal stricture formation following corrosive burns.
  • To evaluate Hesperidin's impact on inflammation, fibrosis, and necrosis in a caustic esophageal injury model.

Main Methods:

  • Experimental corrosive esophageal burns were induced in rats using 20% NaOH.
  • Rats were divided into untreated and Hesperidin-treated groups, with sacrifice at 14 and 21 days.
  • Histopathological evaluation, weight monitoring, and stenosis index assessment were used to determine treatment efficacy.

Main Results:

  • Hesperidin treatment significantly reduced histopathologic damage scores (inflammation, necrosis, fibrosis) compared to untreated groups.
  • The stenosis index was significantly lower in Hesperidin-treated rats, similar to the sham group.
  • Hesperidin-treated rats maintained body weight, unlike untreated rats which showed significant weight loss.

Conclusions:

  • Hesperidin demonstrates effectiveness in mitigating macroscopic and microscopic damage in corrosive esophageal burns.
  • Hesperidin prevents stricture formation and positively influences nutritional status in rats with esophageal burns.
  • This study highlights Hesperidin as a potential therapeutic agent for esophageal caustic injuries.
Abstract

Related Concept Videos

Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
332
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
203
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
362
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
284
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
277
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
504